TransMedics Group Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.41x

TransMedics Group Inc capital reinvestment ratio. TransMedics Group Inc (TMDX) has a Capital Reinvestment Ratio of 0.41x as of June 2026, meaning it reinvests 0% of its operating cash flow ($17.31 Million) in capital expenditures ($7.09 Million). See how much free cash does TransMedics Group Inc generate to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.41x
Capex / Operating Cash Flow

Operating Cash Flow

$17.31 Million
USD

Capital Expenditures

$7.09 Million
USD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of TransMedics Group Inc (2024–2025)

Capital reinvestment ratio of TransMedics Group Inc from 2024 to 2025. This chart tracks TransMedics Group Inc's Capital Reinvestment Ratio across 2 annual periods. See TransMedics Group Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

TransMedics Group Inc Capital Reinvestment Ratio by Year (2024–2025)

TransMedics Group Inc capital reinvestment ratio by year from 2024 to 2025. For the full cash flow conversion analysis, see TMDX operating cash flow.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.31x $192.84 Million $59.25 Million ▼ -88.4%
2024 2.66x $48.80 Million $129.74 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow